Drug Type Small molecule drug |
Synonyms WD106 |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | China | 15 Aug 2020 | |
| Prostatic Cancer | Preclinical | China | 15 Aug 2020 | |
| Prostatic Cancer | Preclinical | China | 15 Aug 2020 |





